&nbsp;

Jun 2019

Drug

thalidomide

Other Name(s): Thalomid®

Quick Link(s):

Jun 2019

Drug

thioguanine

Other Name(s): Lanvis®

Quick Link(s):

Jun 2019

Regimen

THAL

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

thalidomide (Unfunded)

Quick Link(s):

Regimen Monograph

Jun 2019

Regimen

TMXF

Cancer Type:

Sarcoma,

Desmoid Tumour

Intent: Curative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen

Quick Link(s):

Regimen Monograph

May 2019

Regimen

TALI

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Drugs Used:

talimogene laherparepvec (Unfunded)

Quick Link(s):

Regimen Monograph

May 2019

Regimen

TMXFRIBO

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen,

ribociclib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2019

Regimen

TRIP

Cancer Type:

Breast

Intent: Adjuvant, Curative, Palliative

Funding:

ODB - General Benefit

triptorelin

Drugs Used:

triptorelin

Quick Link(s):

Regimen Monograph

May 2019

Guidelines and Advice

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Status: In-Review
ID: GL 6-A-2018-1

Mar 2019

Drug

trametinib

Other Name(s): Mekinist®

Quick Link(s):

Jun 2025

Regimen

TRAM

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

Exceptional Access Program

trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria

Drugs Used:

trametinib